BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., announced the closing of its acquisition of VerdaGenix, LLC, owner of the Ancient Extracts USA wellness platform, marking a milestone in the company's transformation into a scalable operating platform focused on wellness, performance, and human optimization.
With the acquisition complete, Ancient Extracts USA becomes a wholly owned subsidiary of BFCH, bringing an established direct-to-consumer infrastructure, commercial operations, proprietary formulations, intellectual property, supplier relationships, inventory, fulfillment capabilities, digital marketing systems, and a diversified catalog of more than 20 wellness SKUs already in market. Management believes this acquisition significantly de-risks the company's broader operating strategy by providing an active commercial foundation for future growth initiatives.
The transaction follows a series of strategic developments over the past year, including the elimination of over $2 million in legacy convertible debt, strengthening of the balance sheet and governance, restoration of disclosure compliance, acquisition of the EVERMIND intellectual property platform, and expansion of executive leadership.
BFCH is now transitioning Ancient Extracts into a broader commercialization phase, scaling direct-to-consumer operations and pursuing retail distribution opportunities. The company is advancing strategic growth capital initiatives to support inventory expansion, operational scaling, customer acquisition, and retail channel development.
John P. Gorst, CEO of BFCH, stated: "We are not attempting to create a concept from scratch. Ancient Extracts already has operating infrastructure, commercialized products, existing customers, active distribution channels, and a brand foundation capable of meaningful expansion. Our focus now is execution, commercialization scale, and building a significantly larger operating platform around assets we believe possess real long-term value."
Jordan P. Balencic, D.O., Chairman and Chief Science Officer, added: "Closing Ancient Extracts represents a transformational milestone. Our focus now shifts from corporate restructuring and platform assembly toward commercialization, operational execution, and long-term value creation. We believe Ancient Extracts provides a powerful operating nucleus capable of supporting broader growth initiatives across digital commerce and retail distribution channels."
The company expects to announce additional operational milestones, including retail initiatives, strategic partnerships, purchase order activity, and expanded distribution opportunities. Management continues evaluating additional acquisition opportunities and strategic partnerships aligned with its long-term strategy.
Separately, BFCH received a formal legal opinion from securities counsel concluding it is not a shell company under Rule 405 of the Securities Act of 1933, based on its operating strategy, asset base, acquisitions, and ongoing activities.
For more corporate information, visit www.UNLOCKDinc.com. View current filings on OTC Markets.
